- Home
- USFD vs BMRN Comparison
USFD vs BMRN Comparison
Compare USFD & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USFD
- BMRN
- Stock Information
- Founded
- USFD 2007
- BMRN 1996
- Country
- USFD United States
- BMRN United States
- Employees
- USFD N/A
- BMRN N/A
- Industry
- USFD Food Distributors
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- USFD Consumer Discretionary
- BMRN Health Care
- Exchange
- USFD Nasdaq
- BMRN Nasdaq
- Market Cap
- USFD 15.1B
- BMRN 12.1B
- IPO Year
- USFD 2016
- BMRN 1999
- Fundamental
- Price
- USFD $79.13
- BMRN $58.07
- Analyst Decision
- USFD Strong Buy
- BMRN Buy
- Analyst Count
- USFD 11
- BMRN 22
- Target Price
- USFD $81.73
- BMRN $93.43
- AVG Volume (30 Days)
- USFD 2.5M
- BMRN 2.2M
- Earning Date
- USFD 05-08-2025
- BMRN 05-01-2025
- Dividend Yield
- USFD N/A
- BMRN N/A
- EPS Growth
- USFD 7.60
- BMRN 152.82
- EPS
- USFD 2.19
- BMRN 2.71
- Revenue
- USFD $38,279,000,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- USFD $7.14
- BMRN $12.27
- Revenue Next Year
- USFD $5.89
- BMRN $10.08
- P/E Ratio
- USFD $36.20
- BMRN $21.47
- Revenue Growth
- USFD 6.32
- BMRN 19.36
- 52 Week Low
- USFD $50.05
- BMRN $52.93
- 52 Week High
- USFD $79.64
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- USFD 76.02
- BMRN 41.32
- Support Level
- USFD $75.20
- BMRN $57.27
- Resistance Level
- USFD $78.18
- BMRN $59.12
- Average True Range (ATR)
- USFD 1.41
- BMRN 1.40
- MACD
- USFD 0.16
- BMRN 0.06
- Stochastic Oscillator
- USFD 92.89
- BMRN 18.34
About USFD US Foods Holding Corp.
US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.